BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Teijin Board Elects Ichiro Watanabe as New President of Teijin Pharma

  Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that Teijin’s board of directors has elected Ichiro Watanabe, currently corporate officer of the Teijin Group, as its next president.

  February 4, 2019

   · 

  1 min read
• 

  Business

  Ultragenyx Appoints Shehnaaz Suliman, M.D., to Board of Directors

  Ultragenyx Pharmaceutical Inc. announced the appointment of Shehnaaz Suliman, M.D., to the company’s Board of Directors, effective January 30, 2019.

  February 4, 2019

   · 

  2 min read
• Pharm Country

  Carestream Earns Top KLAS Ratings for Vendor-Neutral Archive And Universal Viewer

  Company Also Awarded Best in KLAS for Vue PACS in the Middle East/Africa

  February 4, 2019

   · 

  3 min read
• FDA

  Pharnext Announces FDA Fast Track Designation for PLEODRUG(TM) PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A

  Pharnext SA announced that the U.S. Food and Drug Administration has granted Fast Track designation for the development of PXT3003 for the treatment of patients with Charcot-Marie-Tooth disease Type 1A.

  February 4, 2019

   · 

  5 min read
• Drug Development

  Neurana Pharmaceuticals Announces First Patient Enrolled in the “STAR Study” a Phase 2 Dose Ranging Study of Tolperisone in Acute Muscle Spasms of the Back

  Neurana Pharmaceuticals, a specialty pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that it has enrolled its first patient in the “STAR Study,” a Phase 2 dose ranging study of tolperisone in acute muscle spasms of the back.

  February 4, 2019

   · 

  2 min read
• Pharm Country

  Dr. Reddy’s Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1500mg/100mL Due to Mislabeling

  Dr. Reddy’s Laboratories Ltd. announced that its wholly owned subsidiary, Dr Reddy’s Laboratories, Inc, is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetam in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL single-dose infusion bags to the hospital level in U.S.A.

  February 4, 2019

   · 

  7 min read
• Biotech Beach

  Johnson & Johnson Vision Announces Availability in Europe of TECNIS Eyhance IOL, a Next-Generation Monofocal Intraocular Lens for Patients with Cataracts

  TECNIS Eyhance IOL is the latest innovation in the industry leading TECNIS® Family of Intraocular Lenses

  February 4, 2019

   · 

  10 min read
• Business

  Juvenescence and the Buck Institute Launch New Company to Develop Ketone Body-Based Therapeutics

  New venture expands on collaborations between Juvenescence and The Buck

  February 4, 2019

   · 

  3 min read
• Deals

  CBPE Acquires Majority Investment in CRO Simbec-Orion

  Simbec-Orion Group Limited, a leading European full-service boutique clinical research organisation announced that CBPE Capital LLP has acquired a majority stake in the company.

  February 4, 2019

   · 

  3 min read
• Business

  CollPlant Announces Appointment of Jonathan M.N. Rigby as Chairman of the Board

  CollPlant, a regenerative medicine company, announced that Jonathan M.N. Rigby has been appointed as Chairman of the Board of Directors effective immediately.

  February 4, 2019

   · 

  6 min read